Cargando…

Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis

The use of immune checkpoint inhibitors (iCPI) in the treatment of multiple cancers has gained prominence due to their high efficacy. However, neurological immune-related adverse events (irAEs) such as myasthenia gravis (MG) have been associated with iCPI therapy. Most of these neurological irAEs ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verma, Neha, Jaffer, Muhammad, Pina, Yolanda, Peguero, Edwin, Mokhtari, Sepideh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357079/ https://www.ncbi.nlm.nih.gov/pubmed/34395120 http://dx.doi.org/10.7759/cureus.16337

Ejemplares similares

Rituximab in the Management of Refractory Myasthenia Gravis and Variability of Its Efficacy in Anti-MuSK Positive and Anti-AChR Positive Myasthenia Gravis
por: Bastakoti, Sanjiv, et al.
Publicado: (2021)

Killing Two Birds With One Stone: Successful Management With Rituximab in the Coexistence of Myasthenia Gravis and Marginal Zone Lymphoma
por: Li, Xiao, et al.
Publicado: (2023)

Myasthenia Gravis Associated With COVID-19 Infection
por: Sadiq, Waleed, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
por: Huang, Yi-Te, et al.
Publicado: (2020)

Myasthenia Gravis Related to Small Cell Lung Carcinoma
por: López-Viñas, Laura, et al.
Publicado: (2021)

Coexistence of Pernicious Anemia and Myasthenia Gravis Presenting As Dyspnea
por: Khademolhosseini, Sara, et al.
Publicado: (2021)

An Atypical Presentation of Myasthenia Gravis: A Case Report
por: Asghar, Hannan, et al.
Publicado: (2019)

Symptoms of Myasthenia Gravis Obscured by Old Age and Unilateral Presentation
por: Gracey, Celeste, et al.
Publicado: (2023)

A Diagnostic Dilemma of Dysphonia: A Case Report on Laryngeal Myasthenia Gravis
por: Khan, Asad Ali, et al.
Publicado: (2021)

Rituximab treatment in myasthenia gravis
por: Vesperinas-Castro, Ana, et al.
Publicado: (2023)

Bilateral Facial Palsy Without Ocular Muscle Involvement in Myasthenia Gravis: Case Report
por: Umair, Muhammad, et al.
Publicado: (2022)

Association Between Systemic Lupus Erythematosus and Myasthenia Gravis: Coincidence or Sequelae?
por: Raut, Sumit, et al.
Publicado: (2020)

Choices and Challenges With Treatment of Myasthenia Gravis in Pregnancy: A Systematic Review
por: Kumar, Lakshya, et al.
Publicado: (2023)

Pembrolizumab-Induced Myasthenia Gravis: A Case Report and Review of the Literature
por: Eglenen Polat, Buse, et al.
Publicado: (2023)

Myasthenia Gravis as an Immune-Mediated Side Effect of Checkpoint Inhibitors
por: Heleno, Caio T, et al.
Publicado: (2021)

Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia
por: Takamatsu, Koutaro, et al.
Publicado: (2018)

A Case of COVID-19 Vaccine Causing a Myasthenia Gravis Crisis
por: Tagliaferri, Ariana R, et al.
Publicado: (2021)

Association Between Myasthenia Gravis and Systemic Lupus Erythematosus as a Comorbid State
por: Ali, Moeez, et al.
Publicado: (2021)

Seropositive Muscle-Specific Tyrosine Kinase Myasthenia Gravis Presenting as a Late-Onset Isolated Sixth Nerve Palsy: A Case Report and a Brief Review of Subtypes of Myasthenia Gravis
por: Park, Gyusik, et al.
Publicado: (2021)

Achalasia and Cricopharyngeal Sphincter Dysfunction in a Patient With Myasthenia Gravis: A Case Report
por: Acharya, Sudeep, et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-Induced Polymyositis and Myasthenia Gravis with Fatal Outcome
por: Giglio, Daniel, et al.
Publicado: (2020)

Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis
por: Masi, Gianvito, et al.
Publicado: (2023)

Eculizumab versus rituximab in generalised myasthenia gravis
por: Nelke, Christopher, et al.
Publicado: (2022)

A Case Report and Literature Review of New-Onset Myasthenia Gravis After COVID-19 Infection
por: Chatterjee, Tulika, et al.
Publicado: (2022)

Immunotherapy Induced Myasthenic-Like Syndrome in a Metastatic Melanoma Patient With Amyotrophic Lateral Sclerosis
por: Jaffer, Muhammad, et al.
Publicado: (2020)

Myasthenia Gravis: A Rare Neurologic Complication of Immune Checkpoint Inhibitor Therapy
por: Shames, Yelena, et al.
Publicado: (2022)

Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor
por: Ünlütürk, Zeynep, et al.
Publicado: (2023)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Role of Immune Checkpoint Inhibitors in Advanced or Recurrent Endometrial Cancer
por: Arora, Ena, et al.
Publicado: (2018)

Myocarditis and myositis/myasthenia gravis overlap syndrome induced by immune checkpoint inhibitor followed by esophageal hiatal hernia: A case report and review of the literature
por: Yin, Beibei, et al.
Publicado: (2022)

Selective Type 2 Respiratory Failure Followed by Ocular Myasthenia Gravis Diagnosed by Ice Pack Test: A Case Report
por: Dave, Hitanshu, et al.
Publicado: (2019)

Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
por: Zaremba, Anne, et al.
Publicado: (2019)

Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis
por: Gao, Wen, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Induced Lymphocytic Esophagitis
por: Amin, Shefali, et al.
Publicado: (2023)

Isolated Neutropenia Due to Immune Checkpoint Inhibitors
por: Jalil, Ahmad, et al.
Publicado: (2023)

When Breathing Becomes a Challenge: A Case of Congenital Myasthenia Gravis in an Indian Neonate With a DOK-7 Gene Mutation
por: Mendpara, Vaidehi, et al.
Publicado: (2023)

Rituximab in Refractory Myasthenia Gravis: Experience in a Single Healthcare Center in Mexico
por: López-Hernández, Juan Carlos, et al.
Publicado: (2021)

Case Report: The Neuromusclar Triad of Immune Checkpoint Inhibitors: A Case Report of Myositis, Myocarditis, and Myasthenia Gravis Overlap Following Toripalimab Treatment
por: Luo, Yue-Bei, et al.
Publicado: (2021)

Refractory myasthenia gravis – clinical profile, comorbidities and response to rituximab
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2016)

Influence of Microbiome and Antibiotics on the Efficacy of Immune Checkpoint Inhibitors
por: Patel, Priyanka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7i91dmkrf84a16a076g32gchd4